VHC - Virus Hépatologie Cancer | HENRI MONDOR

Soutenir la recherche
 

Publications and Resources

Sort by :
Display :
181-190 sur 397

Zika virus in the female genital tract.

B Visseaux, E Mortier, N Houhou-Fidouh, Ségolène BRICHLER, G Collin, L Larrouy, C Charpentier, D Descamps,

Lancet Infect Dis. 01/11/2016;16(11) : 1220 10.1016/S1473-3099(16)30387-5.

Hepatitis C RNA assay differences in results: Potential implications for shortened therapy and determination of Sustained Virologic Response.

G Cloherty, Stephane CHEVALIEZ, C Sarrazin, C Herman, V Holzmayer, G Dawson, B Maasoumy, J Vermehren, H Wedemeyer, JJ Feld, Jean-Michel PAWLOTSKY,

Sci Rep. 20/10/2016;6 : 35410 10.1038/srep35410.

Hepatitis C Drugs: Is Next Generation the Last Generation?

Jean-Michel PAWLOTSKY,

Gastroenterology 01/10/2016;151(4) : 587-590 10.1053/j.gastro.2016.08.043 30/08/2016

Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study.

D Saadoun, V Thibault, SN Si Ahmed, L Alric, M Mallet, C Guillaud, H Izzedine, A Plaisier, H Fontaine, M Costopoulos, M Le Garff-Tavernier, Christophe HEZODE, S Pol, L Musset, T Poynard, P Cacoub,

Ann Rheum Dis. 01/10/2016;75(10) : 1777-1782 10.1136/annrheumdis-2015-208339 13/11/2015

Different precore/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severity.

A Ducancelle, A Pivert, S Bertrais, J Boursier, V Balan, P Veillon, H Le Guillou-Guillemette, V Thibault, S Castelain, B Roquebert, M Coste-Burel, V Mackiewicz, E Schvoerer, S Larrat, S Maylin, S Alain, V Loustaud-Ratti, Emmanuel GORDIEN, J Gozlan, V Brodard, Stephane CHEVALIEZ, P Cales, F Lunel-Fabiani,

J Gastroenterol Hepatol. 01/10/2016;31(10) : 1750-1756 10.1111/jgh.13338.

Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France.

P Marcellin, F Zoulim, Christophe HEZODE, X Causse, B Roche, R Truchi, A Pauwels, D Ouzan, J Dumortier, GP Pageaux, M Bourliere, G Riachi, JP Zarski, JF Cadranel, V Tilliet, C Stern, P Petour, O Libert, SM Consoli, D Larrey,

Dig Dis Sci. 01/10/2016;61(10) : 3072-3083 10.1007/s10620-015-4027-8. 28/01/2016

Selection of an early biomarker for vascular normalization using dynamic contrast-enhanced ultrasonography to predict outcomes of metastatic patients treated with bevacizumab

N Lassau, B Coiffier, M Kind, V Vilgrain, L Lacroix, M Cuinet, S Taieb, R Aziza, A Sarran, C Labbe-Devilliers, B Gallix, D Lucidarme, Y Ptak, L Rocher, LM Caquot, S Chagnon, D Marion, Alain LUCIANI, S Feutray, J Uzan-Auqui, B Benatsou, J Bonastre, S Koscielny,

Ann Oncol. 01/10/2016;27(10) : 1922-8 10.1093/annonc/mdw280 08/08/2016

Are cancer outpatients ready for e-medicine?

E Kempf, A Prevost, Benoit ROUSSEAU, I Macquin-Mavier, A Louvet, C Tournigand,

Bull Cancer 01/10/2016;103(10) : 841-848 10.1016/j.bulcan.2016.06.004 03/08/2016

Acute neurovascular events in cancer patients receiving anti-vascular endothelial growth factor agents: Clinical experience in Paris University Hospitals

C Tlemsani, O Mir, D Psimaras, Y Vano, M Ducreux, B Escudier, Benoit ROUSSEAU, D Loirat, B Ceccaldi, P Andre, F Goldwasser, D Ricard,

Eur J Cancer 01/10/2016;66 : 75-82 10.1016/j.ejca.2016.07.008. 15/08/2016

Display :
181-190 sur 397